robert dreicer, md, updates us on the role of cabazitaxel from the card study
Published 4 years ago • 43 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
2:05
robert dreicer, md, describes the results of the javelin-100 bladder cancer trial
-
2:34
robert dreicer, md, on the utilization of psma pet scanning & biomarkers in prostate cancer
-
2:09
robert dreicer, md, provides results presented concerning psma-linked 177lutethium regarding mcrpc
-
0:50
dr. dreicer on future treatment approaches in prostate cancerdreicer
-
0:53
dr. robert dreicer on drug development challenges in prostate cancer
-
0:54
dr. dreicer discusses how new treatments have improved survival
-
5:20
nicholas vogelzang, md, on card study impressions comparing novel hormonal therapy to cabazitaxel
-
0:52
dr. dreicer on the need to diagnose and treat efficiently
-
1:28
dr. dreicer examines prostate cancer advances from the past 10 years
-
2:09
big orterenol study: prostate hopes - dr. robert dreicer
-
0:52
dr. robert dreicer on potential combinations in prostate cancer
-
0:56
dr. dreicer on the treatment of bladder cancer
-
1:09
dr. dreicer on prostate cancer combination therapy
-
0:40
dr. dreicer talks about the state of the healthcare system
-
1:01
dr. robert dreicer on utilizing new prostate cancer therapies
-
3:17
the relationship between prostate cancer treatment efficacy, survival and race | robert dreicer
-
0:58
dr. dreicer on combination trials with radium-223 in mcrpc
-
1:18
dr. robert dreicer on sequencing therapies in prostate cancer
-
0:53
dr. dreicer on combinations and sequencing agents with immunotherapies in prostate cancer